Allergic rhinitis affects an estimated 15% of the US population and is associated with impaired quality of life. JAMA Deputy Editor Mary McGrae McDermott, MD, discusses current evidence regarding the diagnosis and treatment of allergic rhinitis with author Jonathan A. Bernstein, MD, College of Medicine, University of Cincinnati.
Related Content:
The Intersection Between Flu and COVID-19
How to Reopen Schools in the COVID-19 Era
Why Are We Still Talking About Hydroxychloroquine as a Treatment for COVID-19?
A Patient’s Perspective on Nonoperative Treatment of Appendicitis
Updated Pulmonary Embolism Guidelines
The Importance of Minimal Clinically Important Differences in Research Studies
Update on Dexamethasone for the Treatment of COVID-19
Update on Congestive Heart Failure
Treating Pediatric Appendicitis Nonoperatively
Drug Treatment for Primary Prevention of Breast Cancer
Perioperative Risk Assessment
Remdesivir and Dexamethasone for the Treatment of COVID-19
How Is COVID-19 Transmitted?
Complications From SSRIs
Acute Kidney Injury Caused by Proton Pump Inhibitors
Diagnosis and Management of Amyloidosis
A Clinical Pharmacologist's Perspective on Penicillin Allergy
Sample Size Calculation for a Hypothesis Test
Understanding Pragmatic Trials
Overview of Depression
Create your
podcast in
minutes
It is Free
JAMA Editors’ Summary
JAMA Medical News
JAMAevidence The Rational Clinical Examination
JAMA Psychiatry Author Interviews
JAMA Internal Medicine Author Interviews